{
    "2021-02-23": [
        [
            {
                "time": "2021-02-04",
                "original_text": "Big Pharma Short Percentage Is Below Overall Market",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "Short Percentage",
                        "Below",
                        "Overall Market"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "COVID-19 vaccine manufacturing is improving, executives tell Congress",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "vaccine",
                        "manufacturing",
                        "improving",
                        "executives",
                        "Congress"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-06",
                "original_text": "Doctor: We could optimistically reach herd immunity by ‘late summer’",
                "features": {
                    "keywords": [
                        "Doctor",
                        "herd immunity",
                        "optimistically",
                        "late summer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-07",
                "original_text": "Vaccine Makers Promise More Supply as FDA Clears Path for Faster Updates",
                "features": {
                    "keywords": [
                        "Vaccine Makers",
                        "Supply",
                        "FDA",
                        "Faster Updates"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "Lyft partners with CVS to increase accessibility of the COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "Lyft",
                        "CVS",
                        "accessibility",
                        "COVID-19 vaccine"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "transportation",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-09",
                "original_text": "J&J to Deliver 20 Million Doses of COVID Vaccine to U.S. By End of March",
                "features": {
                    "keywords": [
                        "J&J",
                        "Deliver",
                        "Million Doses",
                        "COVID Vaccine",
                        "U.S.",
                        "March"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-10",
                "original_text": "UPDATE 2-S.Africa says J&J, Pfizer, Moderna vaccines those for 'immediate use'",
                "features": {
                    "keywords": [
                        "S.Africa",
                        "J&J",
                        "Pfizer",
                        "Moderna",
                        "vaccines",
                        "immediate use"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-11",
                "original_text": "J&J plans to deliver 20 million doses of its COVID-19 vaccine in the U.S. in March",
                "features": {
                    "keywords": [
                        "J&J",
                        "deliver",
                        "million doses",
                        "COVID-19 vaccine",
                        "U.S.",
                        "March"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-12",
                "original_text": "FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants",
                "features": {
                    "keywords": [
                        "FDA",
                        "Smaller Trials",
                        "Vaccine Efficacy",
                        "COVID Variants"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-13",
                "original_text": "What Are Johnson & Johnson's Chances of Success With Its COVID Vaccine?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Chances",
                        "Success",
                        "COVID Vaccine"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-14",
                "original_text": "Cape Town is testing a Covid-19 vaccine designed to protect against new variants",
                "features": {
                    "keywords": [
                        "Cape Town",
                        "Covid-19 vaccine",
                        "new variants"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-15",
                "original_text": "Johnson & Johnson sets aside almost $4 billion for talc verdict, filing shows",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "talc verdict",
                        "$4 billion"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}